Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic SyndromesBart L. Scott, Mitchell E. Horwitz, Marcelo C. Pasquini et al.|Journal of Clinical Oncology|2017Cited by 664
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual DiseaseChristopher S. Hourigan, Mitchell E. Horwitz, Richard T. Maziarz et al.|Journal of Clinical Oncology|2019Cited by 441
Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant CyclophosphamideAsad Bashey, Mary Eapen, Mei-Jie Zhang et al.|Journal of Clinical Oncology|2017Cited by 325
Secondary solid cancer screening following hematopoietic cell transplantationYoshihiro Inamoto, Navneet S. Majhail, Nirali N. Shah et al.|Bone Marrow Transplantation|2015Cited by 185
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remissionArmin Rashidi, Richard F. Olsson, Mehdi Hamadani et al.|Blood Advances|2019Cited by 128